Evidence map›Paper›PMID 32611441›Full record

ArticleGenome biology2020

Analysis of endothelial-to-haematopoietic transition at the single cell level identifies cell cycle regulation as a driver of differentiation.

Giovanni Canu, Emmanouil Athanasiadis, Rodrigo A Grandy, Jose Garcia-Bernardo, Paulina M Strzelecka, Ludovic Vallier, Daniel Ortmann, Ana Cvejic

Open access · goldAbstract read
In one paragraph

Article in Genome biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. HOXA9 Regulome and Pharmacological Interventions in Leukemia.Advances in experimental medicine and biology · 2024
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Giovanni CanuWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.
Emmanouil AthanasiadisDepartment of Haematology, University of Cambridge, Cambridge, UK.
Rodrigo A GrandyWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.
Jose Garcia-BernardoWellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Cambridge, UK.
Paulina M StrzeleckaWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK.
Ludovic VallierWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK. lv225@cam.ac.uk.
Daniel OrtmannWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK. do267@cam.ac.uk.
Ana CvejicWellcome Trust-Medical Research Council Cambridge Stem Cell Institute, Cambridge, UK. as889@cam.ac.uk.
Wellcome/MRC Cambridge Stem Cell Institute · GBWellcome Sanger Institute · GBMedical Research Council · GBUniversity of Cambridge · GB

Funding

British Heart FoundationCancer Research UK 14953Cancer Research UK C45041/A14953Department of HealthEuropean Research Council 677501Medical Research Council G0701448Medical Research Council MC_PC_12009Medical Research Council MC_PC_17230Medical Research Council MR/M008975/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/N001540/1National Centre for the Replacement, Refinement and Reduction of Animals in Research NC/T2T0419Wellcome Trust
6 · The paper itself

Abstract

backgroundHaematopoietic stem cells (HSCs) first arise during development in the aorta-gonad-mesonephros (AGM) region of the embryo from a population of haemogenic endothelial cells which undergo endothelial-to-haematopoietic transition (EHT). Despite the progress achieved in recent years, the molecular mechanisms driving EHT are still poorly understood, especially in human where the AGM region is not easily accessible.

resultsIn this study, we take advantage of a human pluripotent stem cell (hPSC) differentiation system and single-cell transcriptomics to recapitulate EHT in vitro and uncover mechanisms by which the haemogenic endothelium generates early haematopoietic cells. We show that most of the endothelial cells reside in a quiescent state and progress to the haematopoietic fate within a defined time window, within which they need to re-enter into the cell cycle. If cell cycle is blocked, haemogenic endothelial cells lose their EHT potential and adopt a non-haemogenic identity. Furthermore, we demonstrate that CDK4/6 and CDK1 play a key role not only in the transition but also in allowing haematopoietic progenitors to establish their full differentiation potential.

conclusionWe propose a direct link between the molecular machineries that control cell cycle progression and EHT.

Indexed as

Cell CycleCell DifferentiationCyclin-Dependent KinasesEndothelial CellsHematopoiesisHematopoietic Stem CellsHumansPluripotent Stem CellsSingle-Cell AnalysisCyclin-Dependent Kinases

Identifiers

PMID32611441
PMCPMC7329542
OpenAlexW3039027972

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.